MedTrace Logo

Chronic Neuropathy Following Chemotherapy

NCT02654691 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 63

Last updated 2021-02-25

Study results available
· View outcomes & findings →

Summary

This is a clinical study which is a follow-up of a previous prospective questionnaire study. All patients who previously participated in the study will receive a new questionnaire and will be invited for a clinical examination.

Conditions

Sponsors & Collaborators

  • University of Oxford

    collaborator OTHER

  • Imperial College London

    collaborator OTHER

  • University of Dundee

    collaborator OTHER

  • Mentis Cura

    collaborator INDUSTRY

  • Institut National de la Santé Et de la Recherche Médicale, France

    collaborator OTHER_GOV

  • University of Kiel

    collaborator OTHER

  • Lund University

    collaborator OTHER

  • Technion, Israel Institute of Technology

    collaborator OTHER

  • University Ghent

    collaborator OTHER

  • Neuroscience Technologies S.L.P

    collaborator INDUSTRY

  • Danish Pain Research Center

    lead OTHER

Principal Investigators

  • Kristine J Bennedsgaard, MD · Aarhus University Hospital and Aarhus University

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-06-30
Primary Completion
2017-04-30
Completion
2019-07-01

Countries

  • Denmark

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02654691 on ClinicalTrials.gov